QIAGEN Cash on Hand 2010-2023 | QGEN
QIAGEN cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- QIAGEN cash on hand for the quarter ending March 31, 2023 was $1.287B, a 4.68% increase year-over-year.
- QIAGEN cash on hand for 2022 was $1.418B, a 33.13% increase from 2021.
- QIAGEN cash on hand for 2021 was $1.065B, a 48.94% increase from 2020.
- QIAGEN cash on hand for 2020 was $0.715B, a 17.49% decline from 2019.
QIAGEN Annual Cash on Hand
(Millions of US $) |
| 2022 |
$1,418 |
| 2021 |
$1,065 |
| 2020 |
$715 |
| 2019 |
$867 |
| 2018 |
$1,496 |
| 2017 |
$1,024 |
| 2016 |
$532 |
| 2015 |
$421 |
| 2014 |
$577 |
| 2013 |
$380 |
| 2012 |
$484 |
| 2011 |
$276 |
| 2010 |
$934 |
| 2009 |
$866 |
QIAGEN Quarterly Cash on Hand
(Millions of US $) |
| 2023-03-31 |
$1,287 |
| 2022-12-31 |
$1,418 |
| 2022-09-30 |
$1,887 |
| 2022-06-30 |
$1,311 |
| 2022-03-31 |
$1,230 |
| 2021-12-31 |
$1,065 |
| 2021-09-30 |
$957 |
| 2021-06-30 |
$898 |
| 2021-03-31 |
$792 |
| 2020-12-31 |
$715 |
| 2020-09-30 |
$768 |
| 2020-06-30 |
$899 |
| 2020-03-31 |
$903 |
| 2019-12-31 |
$867 |
| 2019-09-30 |
$804 |
| 2019-06-30 |
$932 |
| 2019-03-31 |
$940 |
| 2018-12-31 |
$1,496 |
| 2018-09-30 |
$921 |
| 2018-06-30 |
$900 |
| 2018-03-31 |
$1,014 |
| 2017-12-31 |
$1,024 |
| 2017-09-30 |
$975 |
| 2017-06-30 |
$609 |
| 2017-03-31 |
$273 |
| 2016-12-31 |
$532 |
| 2016-09-30 |
$464 |
| 2016-06-30 |
$406 |
| 2016-03-31 |
$447 |
| 2015-12-31 |
$421 |
| 2015-09-30 |
$432 |
| 2015-06-30 |
$372 |
| 2015-03-31 |
$401 |
| 2014-12-31 |
$577 |
| 2014-09-30 |
$692 |
| 2014-06-30 |
$655 |
| 2014-03-31 |
$678 |
| 2013-12-31 |
$380 |
| 2013-09-30 |
$356 |
| 2013-06-30 |
$373 |
| 2013-03-31 |
$461 |
| 2012-12-31 |
$484 |
| 2012-09-30 |
$311 |
| 2012-06-30 |
$266 |
| 2012-03-31 |
$275 |
| 2011-12-31 |
$276 |
| 2011-09-30 |
$486 |
| 2011-06-30 |
$953 |
| 2011-03-31 |
$939 |
| 2010-12-31 |
$934 |
| 2010-09-30 |
$887 |
| 2010-06-30 |
$918 |
| 2010-03-31 |
$889 |
| 2009-12-31 |
$866 |
| 2009-09-30 |
$861 |
| 2009-06-30 |
$390 |
| 2009-03-31 |
$337 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$10.584B |
$2.142B |
|
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
|
